Comparison Between QR678 Neo And Platelet Rich Plasma For Hair Growth: A Retrospective Study

This retrospective study compared the efficacy of QR678 Neo, a biomimetic peptide-based treatment, and platelet-rich plasma (PRP) in 70 patients with androgenetic alopecia over 6 months. QR678 Neo demonstrated a 30% improvement in hair density compared to an 18% improvement with PRP, with statistical significance (p<0.05). Additionally, QR678 Neo outperformed PRP in all evaluated parameters, including hair quality and patient satisfaction, suggesting it as a consistent and effective alternative for treating androgenetic alopecia.